Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Deferred Taxes (2016 - 2023)

Historic Deferred Taxes for Amicus Therapeutics (FOLD) over the last 3 years, with Q1 2023 value amounting to -$4.9 million.

  • Amicus Therapeutics' Deferred Taxes changed N/A to -$4.9 million in Q1 2023 from the same period last year, while for Dec 2023 it was -$4.9 million, marking a year-over-year decrease of 5497777.78%. This contributed to the annual value of -$4.9 million for FY2023, which is 5497777.78% down from last year.
  • Per Amicus Therapeutics' latest filing, its Deferred Taxes stood at -$4.9 million for Q1 2023.
  • Over the past 5 years, Amicus Therapeutics' Deferred Taxes peaked at $9000.0 during Q4 2022, and registered a low of -$4.9 million during Q1 2023.